← Back to Search

Immunotherapy

Boiled Peanut Powder for Peanut Allergy (BPOIT Trial)

Phase 1

Waitlist Available

Led By Jaclyn Bjelac, MD

Research Sponsored by Alton Melton

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 weeks

Awards & highlights

BPOIT Trial Summary

This trial is testing whether boiled peanuts can help treat peanut allergies in children, and whether the treatment is better than a placebo.

Eligible Conditions

Peanut Allergy

BPOIT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Increase in tolerance to peanut in pediatric patients with peanut hypersensitivity.

Side effects data

From 2012 Phase 2 & 3 trial • 4 Patients • NCT00090493

75%

DVT

75%

Staphyloccocal infections

25%

Shingles

100%

80%

60%

40%

20%

Study treatment Arm

MAGE-A3 AND NY-ESO-1 IMMUNOTHERAPY

BPOIT Trial Design

1Treatment groups

Experimental Treatment

Group I: Boiled Peanut PowderExperimental Treatment1 Intervention

Boiled Peanut Powder

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Alton MeltonLead Sponsor

The Cleveland ClinicOTHER

1,026 Previous Clinical Trials

1,366,066 Total Patients Enrolled

Jaclyn Bjelac, MDPrincipal InvestigatorStaff

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age range for this clinical experiment restricted to individuals younger than 45?

"This clinical trial requires all applicants to fall within the 1 Year - 16 Age range. Concomitantly, 85 studies for minors and 156 for seniors are being conducted in tandem with this research."

Answered by AI

Is there any risk associated with consuming Boiled Peanut Powder?

"Our safety rating for Boiled Peanut Powder has been provisionally set at 1, as this is a Phase 1 trial with minimal existing data regarding its efficacy or safety."

Answered by AI

What qualifications are necessary for individuals to participate in this clinical trial?

"To be considered for this clinical trial, participants must have peanut allergies and fall between 1 year to 16 years of age. At maximum, 10 patients will be accepted into the study."

Answered by AI

Is enrollment still ongoing for this clinical trial?

"According to clinicaltrials.gov, this specific trial is no longer actively recruiting participants; the study was first published on November 5th 2019 and last updated October 21st 2022. Nevertheless, 259 other studies are currently in search of volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Boiled Peanut Oral Immunotherapy

Alton Melton 2019. "Boiled Peanut Oral Immunotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04090203.